Streaming issues? Report here
Temp 702 logo 1000 x 1000 2020 Temp 702 logo 1000 x 1000 2020
Best of 702
00:00 - 06:00
volume_up
volume_mute

Up Next: Weekend Breakfast with Refiloe Mpakanyane
See full line-up
Best of 702
00:00 - 06:00
Home
arrow_forward
Local

Sahpra rejects use of the Russia’s Sputnik V Covid-19 vaccine over HIV concerns

18 October 2021 7:48 PM
Tags:
HIV
Russia
Sahpra
Sputnik V vaccine
Covid-19 vaccination
Sputnik V

Bruce Whitfield speaks to Joan van Dyk, senior journalist at Bhekisisa Health Journalism Centre.
  • Concerns had been raised about some components of the vaccine which could put the population at greater risk of HIV infection
  • South Africa has one of the highest HIV infection rates in the world
  • The use of the vaccine in South Africa would be reviewed at a later date for possible use in future

Russia's Sputnik V Covid-19 vaccine. © Kittipong Satrinekarn/123rf.com

The South African Health Products Authority (Sahpra) on Monday announced that the Sputnik V COVID-19 vaccine will not be approved for use in South Africa.

Sahpra cited concerns about the safety of some components of the vaccine which could put some people, particularly men at greater risk of HIV infection.

The Sputnik V Covid-19 vaccine is a two dose jab, similar to the Pfizer vaccine which is being used in South Africa.

It's a two dose vaccine, like the Pfizer one. It's not a mRNA vaccine, it's an adenovirus vaccine, which means the trojan horse that sneaks this little antibody into your body is called an adenovirus.

Joan van Dyk - Senior journalist at Bhekisisa Health Journalism Centre 

The second jab uses a different kind of virus than the first one. The other vaccines don't do that. This specific trojan horse is called a adenovirus type 5, and that's the one that Sahpra has an issue with.

Joan van Dyk - Senior journalist at Bhekisisa Health Journalism Centre 

With previous HIV research, we've seen some worrying results that if you have exposure to this vector, there's an increase risk of infection for HIV negative people.

Joan van Dyk - Senior journalist at Bhekisisa Health Journalism Centre 

RELATED: Russian Sputnik V Covid-19 vaccine is safe and 92% effective – The Lancet

It's more of a risk for HIV negative people. That's particularly significant for South Africa. We have such a high number of HIV infections every year. We have 15% of the population living with the virus.

Joan van Dyk - Senior journalist at Bhekisisa Health Journalism Centre 

Surprisingly, the Sputnik V vaccine is used in over 70 countries at the moment. It's been approve by many countries. Brazil, Egypt, India, Mexico. It's important to note, none of the regulatory bodies that approved the vaccine, appear on the WHO's list of stringent and strict, reliable regulators.

Joan van Dyk - Senior journalist at Bhekisisa Health Journalism Centre 

Scroll to the top of the article to listen to the interview.




18 October 2021 7:48 PM
Tags:
HIV
Russia
Sahpra
Sputnik V vaccine
Covid-19 vaccination
Sputnik V

More from Local